...
首页> 外文期刊>Investigative ophthalmology & visual science >Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells.
【24h】

Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells.

机译:烷基磷酸胆碱抑制人视网膜色素上皮细胞的增殖。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To investigate the effect and mechanism of action of alkylphosphocholines (APCs) on proliferation of human retinal pigment epithelium (RPE) cells and RPE-mediated collagen matrix contraction in vitro. METHODS: Cultured RPE cells of five human donors were treated with four APCs in the presence of fetal calf serum. Proliferation was assessed by the tetrazolium dye-reduction (MTT) assay and by counting the number of cells dividing in culture. The effect of APCs on RPE-mediated matrix contraction was determined in three-dimensional collagen gels. Cell viability was tested by the trypan blue exclusion assay. As a possible mechanism of APC action, protein kinase C (PKC) activity was quantified by scintillation counting of (32)P-labeled phosphate transferred to a PKC-specific substrate. RESULTS: All APCs inhibited RPE proliferation and RPE-mediated collagen matrix contraction in a dose-dependent manner in vitro. The antiproliferative and anticontractile effect of APCs increased with elongation of thefatty acid chain beyond C20. IC(50)s of all APCs varied between 8.5 micro M (erucyl-phosphocholine, C22:1-PC), 9.0 micro M (Z)-12-heneicosenyl-phosphocholine, C21:1-PC), 11.0 micro M (Z)-10-eicosenyl-phosphocholine, C20:1-PC), and 26.5 micro M (oleyl-phosphocholine, C18:1-PC). Trypan blue staining revealed a toxicity below 5% for all APCs within the concentration interval tested. PKC activity was significantly reduced by all four APCs, with C22:1-PC being the most effective. CONCLUSIONS: APCs inhibit proliferation of RPE cells and RPE-mediated matrix contraction in vitro at nontoxic concentrations. This effect seems to be exerted through inhibition of PKC activity. Therefore, APCs are promising candidates for treatment of RPE-mediated proliferative processes such as proliferative vitreoretinopathy.
机译:目的:探讨烷基磷酸胆碱(APCs)在体外对人视网膜色素上皮细胞(RPE)增殖和RPE介导的胶原基质收缩的作用及其作用机理。方法:在胎牛血清存在的情况下,用四种APC处理五名人类供体的RPE细胞。通过四唑鎓染料还原(MTT)测定并通过计数在培养物中分裂的细胞数来评估增殖。在三维胶原凝胶中确定了APC对RPE介导的基质收缩的影响。通过台盼蓝排除试验测试细胞活力。作为APC作用的可能机制,通过闪烁计数转移至PKC特异性底物的(32)P标记的磷酸盐来定量蛋白激酶C(PKC)活性。结果:所有APCs在体外均以剂量依赖的方式抑制RPE增殖和RPE介导的胶原基质收缩。 APCs的抗增殖和抗收缩作用随C20上方脂肪酸链的延长而增加。所有APC的IC(50)在8.5 micro M(芥子酰基磷酸胆碱,C22:1-PC),9.0 micro M(Z)-12-二十碳烯基磷酸胆碱,C21:1-PC)和11.0 micro M(Z )-10-二十碳烯基磷酸胆碱(C20:1-PC)和26.5 micro M(油基磷酸胆碱,C18:1-PC)。台盼蓝染色显示,在所测试的浓度范围内,所有APC的毒性均低于5%。四种APC均显着降低PKC活性,其中C22:1-PC最有效。结论:APCs在无毒浓度下可抑制RPE细胞的增殖和RPE介导的基质收缩。这种作用似乎是通过抑制PKC活性发挥的。因此,APCs是治疗RPE介导的增生过程(如增生性玻璃体视网膜病变)的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号